Skip to main content
Lenvatinib extends time to disease progression in HCC patients with portal vein tumor thrombus
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Lenvatinib extends time to disease progression in HCC patients with portal vein tumor thrombus
User login
Username
Password
Reset your password
Type
Lead
score
Edit Tags